Skip to main content
Start triage

Start triage first, then route to emergency care.

Need urgent help? Start triage first, then route to emergency care.

Roxee Medication Guide

Famotidine

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Source review pending Source coverage pending Owner quick guide first

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts
Source review pending
No refresh timestamp yet

Roxee is still reviewing source support for this medication profile.

FDA applications
Regulatory match pending
No refresh timestamp yet

Roxee has safety or ingredient evidence for this medication, but a regulatory product/application match is still pending.

Safety reports
Safety data refreshed
Aug 6, 2026, 7:49 p.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Reference facts: Source Roxee | Refreshed Jul 22, 2026, 7:08 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Illustration placeholder
Famotidine

Famotidine

Drug type: Generic ingredient • Generic profile Source coverage pending

Both 85% reference complete

Species: Both

Approval status: Source coverage pending. Roxee has limited supporting content for this record, but no on-page official FDA animal-drug document is linked yet. Treat it as source-limited until the ETL backfill adds official coverage.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Famotidine

Acid-reducing medication used for GI upset and reflux. Species commonly shown: Both.

Generic name
Famotidine
Species
Both
Completeness
85%
Validation
Incomplete

Indications / Uses

Acid-reducing medication used for GI upset and reflux.

Administration / How To Give

Oral

Storage

Store at room temperature.

Warnings / Contraindications

Dose adjustments may be needed in kidney disease.

  • Dose adjustments may be needed in kidney disease.

Side Effects

Generally well tolerated; occasional GI upset.

FAQ

Both

Store at room temperature.

Source Transparency

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

Acid-reducing medication used for GI upset and reflux.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • Dose adjustments may be needed in kidney disease
  • wobbly/unsteady walking (1 reports)
  • Loss of appetite (1 reports)
  • Decreased red blood cell count (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?

Next actions

Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Famotidine; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA case USA-USFDACVM-2025-US-069686
Safety signal coverage Reported signals

32 tracked reaction signals; 32 reported cases; 26 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA case USA-USFDACVM-2025-US-069686
Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA case USA-USFDACVM-2025-US-069686
Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Unsteady walking (ataxia) (1 reports), Loss of appetite (1 reports), Decreased red blood cell count (1 reports), Decreased haematocrit (1 reports), Decreased appetite (1 reports)

Body systems represented Signal grouping

Digestive (2), Skin & allergy (1), Neurologic (1), Behavior (2)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Dog (23 reports), Cat (9 reports)

Breed metadata in reports Metadata only

['Pit Bull', 'Crossbred Canine/dog'] (1), Shih Tzu (1), ['Retriever - Golden', 'Poodle (unspecified)'] (1), Chihuahua (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Famotidine fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

Dose adjustments may be needed in kidney disease, wobbly/unsteady walking, Loss of appetite, Decreased red blood cell count

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Famotidine brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
  1. openFDA case USA-USFDACVM-2025-US-069686 · adverse_reaction · adverse reactions
  2. Medication contraindications · safety_warning · warnings contraindications

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: April 15, 2026, 10:04 AM UTC

Safety & side effects

Side effects to monitor:

  • Dose adjustments may be needed in kidney disease
  • wobbly/unsteady walking
  • Loss of appetite
  • Decreased red blood cell count

Most reported reactions:

  • Unsteady walking (ataxia) (1 reports)
  • Loss of appetite (1 reports)
  • Decreased red blood cell count (1 reports)
Explore reported case details

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species
Not linked yet
Indication / use
Acid-reducing medication used for GI upset and reflux.
Form / route / dose
Confirm product label and patient-specific plan.
Warnings
  • High: Dose adjustments may be needed in kidney disease.
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs
No source documents linked yet.

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Manufacturer not confirmed

Warnings / Contraindications

Dose adjustments may be needed in kidney disease.

  • High: Dose adjustments may be needed in kidney disease.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
26
Matching reports
26
Active filters
0
Reset
Showing up to 50 matching reports.

USA-USFDACVM-2026-US-013926

Received 2026-03-19 · MSK · MSK

Non-serious
Species
Dog
Breed
['Pit Bull', 'Crossbred Canine/dog']
Age
1-3 years (2.67 Year)
Sex
Female Neutered
Region
USA
Reactions
CoughAbnormal radiograph findingHeart murmurEosinophiliaLack of efficacy (endoparasite) - heartworm
Body systems
OtherEffectiveness
Outcomes
Ongoing

USA-USFDACVM-2026-US-012816

Received 2026-03-17 · MSK · MSK

Serious
Species
Dog
Breed
Shih Tzu
Size / weight
Under 10 lb (3.175 Kilogram)
Age
Under 1 year (6 Month)
Sex
Female Unknown
Region
USA
Reactions
Soft stoolNot eatingLow amylase
Body systems
Other
Outcomes
Ongoing

USA-USFDACVM-2026-US-012837

Received 2026-03-16 · MSK · MSK

Serious
Species
Dog
Breed
['Retriever - Golden', 'Poodle (unspecified)']
Size / weight
25-49 lb (16.783 Kilogram)
Age
1-3 years (3 Year)
Sex
Male Neutered
Region
USA
Reactions
VomitingSwelling around eye (see also Immune system disorders)WhiningUncomfortableFeverInjected scleraPinnal erythemaHypersensitivity reaction
Body systems
DigestiveSkin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2026-US-012640

Received 2026-03-16 · MSK · MSK

Serious
Species
Dog
Breed
Chihuahua
Size / weight
Under 10 lb (2.54 Kilogram)
Age
8+ years (8.25 Year)
Sex
Female Unknown
Region
USA
Reactions
Muscle tremorOpisthotonusRigidity of limbsStar-gazingProlonged anaesthesiaIntentional misuse
Body systems
NeurologicOther
Outcomes
Recovered/Normal

USA-USFDACVM-2026-US-012695

Received 2026-03-13 · MSK · MSK

Serious
Species
Dog
Breed
Dalmatian
Size / weight
50-99 lb (36.741 Kilogram)
Age
8+ years (1 Year)
Sex
Male Neutered
Region
USA
Reactions
AgitationDroolingFebrilePantingAnaphylaxisUnwellDecreased appetiteUrinary incontinenceVomitingDiarrhoeaLeukocytosis NOSNeutrophiliaLymphocytosisMonocytosisElevated globulinsElevated serum alkaline phosphatase (ALP)Anaemia NOSElevated alanine aminotransferase (ALT)Elevated C-reactive proteinAggressionUrolithiasisAutoimmune disorder NOSThrombocytopenia
Body systems
OtherDigestiveBehavior
Outcomes
Ongoing

USA-USFDACVM-2026-US-012003

Received 2026-03-13 · MSK · MSK

Non-serious
Species
Cat
Breed
Persian
Size / weight
Under 10 lb (3.36 Kilogram)
Age
8+ years (11 Year)
Sex
Female Neutered
Region
USA
Reactions
Hypersalivation
Body systems
Digestive
Outcomes
Recovered/Normal

USA-USFDACVM-2026-US-009390

Received 2026-02-23 · MSK · MSK

Non-serious
Species
Dog
Breed
Terrier - Bull - Staffordshire
Size / weight
50-99 lb (30.617 Kilogram)
Age
8+ years (8 Year)
Sex
Male Neutered
Region
USA
Reactions
Swollen limbInjection site inflammationLack of efficacy (neoplasia, no remission)
Body systems
OtherEffectiveness
Outcomes
Recovered/Normal

USA-USFDACVM-2026-US-010643

Received 2026-02-12 · MSK · MSK

Non-serious
Species
Dog
Breed
Retriever - Golden
Size / weight
50-99 lb (30.844 Kilogram)
Age
4-7 years (6 Year)
Sex
Female Unknown
Region
USA
Reactions
Localised pain NOS (see other SOCs for specific pain)Limb non-weight bearingSwollen limbWhiningUncomfortablePain NOSReluctant to moveInappropriate urinationAbnormal urine odourInjection site bleedingAnorexiaInjection site itchingInjection site irritationInjection site self traumaLimpingInjection site discharge NOSSkin irritationReddening of the skinAlopecia localInjection site scratchingInjection site swellingInjection site hair loss
Body systems
OtherDigestiveSkin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2026-US-007418

Received 2026-02-09 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (8.7 Kilogram)
Age
1-3 years (2.8 Year)
Sex
Male Neutered
Region
USA
Reactions
Lack of efficacy - NOSNot eatingLethargy (see also Central nervous system depression in Neurological)General pain (see other SOCs for specific pain)Facial oedemaTrigeminus paralysisOral ulcerationIntentional misuse
Body systems
EffectivenessOtherNeurologic
Outcomes
Ongoing

USA-USFDACVM-2026-US-004302

Received 2026-01-27 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Mediumhair
Size / weight
10-24 lb (4.62 Kilogram)
Age
1-3 years (2 Year)
Sex
Female Neutered
Region
USA
Reactions
EmesisNot eatingHidingHyperglycaemiaFeverTachycardiaTachypnoeaBloody stoolWeight lossGall bladder & bile duct disorder NOSGastric distensionIntestinal thickeningDiarrhoea
Body systems
DigestiveOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-074895

Received 2025-12-19 · MSK · MSK

Serious
Species
Dog
Breed
Bloodhound
Size / weight
50-99 lb (41.28 Kilogram)
Age
4-7 years (5 Year)
Sex
Female Neutered
Region
USA
Reactions
Lethargy (see also Central nervous system depression in Neurological)Stiffness NOSWalking difficultyGeneralised weaknessNeutropeniaLow platelet countPain NOSDecreased appetiteVomitingElevated liver enzymes NOSFluid in abdomen NOSLiver disorder NOSOther immune system disorder NOSFeverLeucopenia NOSDistension of abdomenHypoglycaemiaAnaemia NOSIndigestion
Body systems
NeurologicOtherDigestive
Outcomes
Ongoing

USA-USFDACVM-2025-US-074361

Received 2025-12-18 · MSK · MSK

Serious
Species
Dog
Breed
['Terrier - Jack Russell', 'Terrier - Bull - American Pit']
Size / weight
25-49 lb (17.236 Kilogram)
Age
1-3 years (1 Year)
Sex
Female Unknown
Region
USA
Reactions
Emesis (multiple)Hives (see also Skin)Reddening of the skinSkin irritationUrine leakageHypersensitivity reaction
Body systems
DigestiveSkin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-074553

Received 2025-12-17 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (3.969 Kilogram)
Age
8+ years (12 Year)
Sex
Female Unknown
Region
USA
Reactions
Not eatingNot drinkingVomiting bileDeath by euthanasia
Body systems
OtherDigestive
Outcomes
Euthanized

USA-USFDACVM-2025-US-074064

Received 2025-12-15 · MSK · MSK

Serious
Species
Dog
Breed
['Bichon Frise', 'Chihuahua']
Size / weight
Under 10 lb (3.493 Kilogram)
Age
8+ years (15 Year)
Sex
Female Unknown
Region
USA
Reactions
Seizure NOSAtaxiaUrinary incontinence
Body systems
NeurologicOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-072814

Received 2025-12-10 · MSK · MSK

Serious
Species
Dog
Breed
Pinscher - Miniature
Size / weight
Under 10 lb (4.037 Kilogram)
Age
8+ years (1 Year)
Sex
Female Unknown
Region
USA
Reactions
Lethargy (see also Central nervous system depression in Neurological)TremblingLimpingHead downWalking difficultyFeverLack of efficacy - NOSElevated globulinsBlood in urineImmune-mediated polyarthropathyElevated protein:creatinine ratioProteinuriaIntentional misuse
Body systems
NeurologicOtherEffectiveness
Outcomes
Ongoing

USA-USFDACVM-2025-US-072755

Received 2025-12-10 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Mediumhair
Size / weight
10-24 lb (4.627 Kilogram)
Age
1-3 years (2 Year)
Sex
Female Unknown
Region
USA
Reactions
EmesisNot eatingHidingHyperglycaemiaFeverTachycardiaTachypnoeaBloody stoolWeight lossGall bladder & bile duct disorder NOSGastric distensionIntestinal thickeningDiarrhoea
Body systems
DigestiveOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-072294

Received 2025-12-10 · MSK · MSK

Non-serious
Species
Dog
Breed
['Retriever - Golden', 'Dog (unknown)']
Size / weight
50-99 lb (27.48 Kilogram)
Age
1-3 years (2.66 Year)
Sex
Male Neutered
Region
USA
Reactions
Hives (see also Skin)Local erythema
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-072451

Received 2025-12-01 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (5.69 Kilogram)
Age
4-7 years (7 Year)
Sex
Male Neutered
Region
USA
Reactions
Lethargy (see also Central nervous system depression in Neurological)AnorexiaElevated total bilirubinElevated gamma-glutamyl transferase (GGT)Elevated serum alkaline phosphatase (ALP)Elevated alanine aminotransferase (ALT)JaundiceEnlarged liverHidingNausea
Body systems
NeurologicDigestiveOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-071623

Received 2025-12-01 · MSK · MSK

Serious
Species
Dog
Breed
['Retriever - Labrador', 'Dog (unknown)']
Size / weight
25-49 lb (17.69 Kilogram)
Age
8+ years (12 Year)
Sex
Male Neutered
Region
USA
Reactions
VomitingNot eatingWeight lossIcterusLeucopenia NOSDecreased red blood cell countThrombocytopeniaElevated alanine aminotransferase (ALT)Elevated serum alkaline phosphatase (ALP)Elevated total bilirubinHigh pancreatic-specific lipaseUrinary incontinenceInfectious disease NOSOverdoseGall bladder & bile duct disorder NOSLymphopeniaNeutropeniaSplenomegalyLoose stoolPancreas disorderHepatomegalyDeath by euthanasiaHypoalbuminaemiaHypoproteinaemiaFluid in abdomen NOSElevated blood urea nitrogen (BUN)Elevated bile acidsAbnormal ultrasound findingElevated cholesterol (total)Enlarged lymph node (localised)Reduced globulinsMonocytopeniaEosinopeniaLiver nodules
Body systems
DigestiveOther
Outcomes
Euthanized

USA-USFDACVM-2025-US-072103

Received 2025-11-26 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (7.66 Kilogram)
Age
8+ years (13.1 Year)
Sex
Male Neutered
Region
USA
Reactions
Dry coatDull reflexesElevated blood urea nitrogen (BUN)Elevated creatinineHyperphosphataemiaHypokalaemiaHypertrophic concentric cardiomyopathyDecreased haematocritSyncopeHypertension
Body systems
Other
Outcomes
Ongoing

USA-USFDACVM-2025-US-074528

Received 2025-11-25 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Mediumhair
Size / weight
Under 10 lb (4.13 Kilogram)
Age
1-3 years (2 Year)
Sex
Female Neutered
Region
USA
Reactions
AnorexiaReluctant to moveVocalisationLoss of bowel controlNot urinatingEosinopeniaBasophiliaHypernatremiaThrombocytopeniaAbnormal radiograph findingThird eyelid protrusionOther ear disorder NOS
Body systems
DigestiveOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-072580

Received 2025-11-25 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Mediumhair
Size / weight
Under 10 lb (4.13 Kilogram)
Age
1-3 years (2 Year)
Sex
Female Neutered
Region
USA
Reactions
Reluctant to moveVocalisationLoss of bowel controlNot urinatingEosinopeniaBasophiliaHypernatremiaThrombocytopeniaAbnormal radiograph findingThird eyelid protrusionOther ear disorder NOSNasal dischargeFalling
Body systems
Other
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-074135

Received 2025-11-20 · MSK · MSK

Serious
Species
Dog
Breed
Retriever - Labrador
Size / weight
50-99 lb (28.576 Kilogram)
Age
8+ years (12 Year)
Sex
Male Neutered
Region
USA
Reactions
Application site dry skinLack of efficacy (neoplasia, no remission)Injection site hair lossInjection site scabMast cell tumourLocal swelling (not application site)Swollen eye
Body systems
OtherEffectivenessSkin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-068768

Received 2025-11-14 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Mediumhair
Size / weight
Under 10 lb (4.13 Kilogram)
Age
1-3 years (2 Year)
Sex
Female Neutered
Region
USA
Reactions
AnorexiaReluctant to moveVocalisationLoss of bowel controlNot urinatingEosinopeniaBasophiliaHypernatremiaThrombocytopeniaAbnormal radiograph findingThird eyelid protrusionOther ear disorder NOS
Body systems
DigestiveOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-067552

Received 2025-11-13 · MSK · MSK

Serious
Species
Dog
Breed
Shepherd Dog - German
Size / weight
50-99 lb (40.37 Kilogram)
Age
8+ years (9 Year)
Sex
Male Neutered
Region
USA
Reactions
Injection site painNot himself/herselfVomitingWobblinessUnexplained death
Body systems
OtherDigestive
Outcomes
Died

USA-USFDACVM-2025-US-069686

Received 2025-11-12 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (3.9 Kilogram)
Age
8+ years (14 Year)
Sex
Female Neutered
Region
USA
Reactions
Swollen limbEpistaxisDeath by euthanasiaMalaiseHeart murmurNeutropeniaThrombocytopeniaHypoalbuminaemiaIncreased drinkingHaematuriaDecreased urine concentrationElevated protein:creatinine ratioDehydrationLymphopeniaAbdominal painIntestinal disorder NOSAbnormal radiograph findingRenal failureRenal disorder NOSInflammatory bowel disorderBronchopulmonary inflammationBruisingAnaemia NOSTachycardiaPale mucous membraneElevated alanine aminotransferase (ALT)Prolonged one stage prothrombin time (OSPT)Intentional misuseMedication error NOSPolyuriaAnorexiaAzotaemiaNecropsy performedHaemorrhage NOSFractureThyroid adenomaPancreas disorder
Body systems
OtherDigestive
Outcomes
Euthanized

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
26
Species represented
2
Grouped by Body System
Digestive (2) · Loss of appetite, Decreased appetite Skin & allergy (1) · Alopecia local Neurologic (1) · Unsteady walking (ataxia) Behavior (2) · Behavioral disorder (unspecified), Aggression Other (26) · Decreased red blood cell count, Decreased haematocrit, Death by euthanasia
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Neurologic 1 Dog 1
Digestive 1 Cat 1
Other 1 Dog 1
Other 1 Cat 1
Digestive 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1

Species coverage: Dog (23) Cat (9)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Dog Serious - 1
Digestive Cat Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Digestive Dog Serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Behavior Dog Serious - 1
Other Cat Serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Skin & allergy Dog Non-serious - 1
Other Dog Serious - 1
Behavior Dog Serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Cat Serious - 1
Source metadata:

Storage & Handling

Store at room temperature.

Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Reference facts: Source Roxee | Refreshed Jul 22, 2026, 7:08 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Official (FDA)
Identity: Generic ingredient • No FDA branded products linked
No official FDA brand rows linked yet for this ingredient.
Case-reported brands (openFDA): MSK
Catalog species: Both
Safety (openFDA)
Top reactions: Dog 127 Cat 85 View
Case summaries: 26 (showing 8) View
openFDA reports are unverified and do not prove causation.

Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Dose adjustments may be needed in kidney disease. (Contraindication, High)
Top reaction signals
Unsteady walking (ataxia) (1) Loss of appetite (1) Decreased red blood cell count (1) Decreased haematocrit (1) Decreased appetite (1) Death by euthanasia (1) Corneal ulcer (1) Cognitive disorder NOS (1)

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 0 Clinical 120 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-22)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-22)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-22)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-20)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-19)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-16)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-16)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-13)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-12)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-11)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-11)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-11)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-10)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-07)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-06)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-06)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-03)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-03)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-02)
  • contraindications: Dose adjustments may be needed in kidney disease. (Clinical, 2026-07-01)
Recent Revisions
  • side_effects updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-16 15:43 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-07-16 15:43 by etl_backfill • Backfilled from existing medication fields

Usage

Acid-reducing medication used for GI upset and reflux.

Contraindications

Dose adjustments may be needed in kidney disease.

Side Effects

Generally well tolerated; occasional GI upset.

Source: FDA openFDA • Reference

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Loss of appetite (1) • Cat Decreased appetite (1) • Dog

Showing top 5 for Digestive.

Skin & allergy
Alopecia local (1) • Dog

Showing top 5 for Skin & allergy.

Neurologic
Unsteady walking (1) • Dog

Showing top 5 for Neurologic.

Behavior
Behavioral disorder (1) • Dog Aggression (1) • Dog

Showing top 5 for Behavior.

Other
Decreased red blood cell count (1) • Dog Decreased haematocrit (1) • Cat Death by euthanasia (1) • Dog Cough (1) • Dog Corneal ulcer (1) • Dog
Show more (21)
Cognitive disorder NOS (1) • Dog Bruising (1) • Cat Bronchopulmonary inflammation (1) • Cat Bradycardia (1) • Cat Bloody stool (1) • Cat Blood in urine (1) • Dog Basophilia (1) • Cat Balance impaired (1) • Dog Bacterial skin infection NOS (1) • Dog Azotaemia (1) • Cat Autoimmune disorder NOS (1) • Dog Arthritis (1) • Dog Application site dry skin (1) • Dog Anaphylaxis (1) • Dog Anaemia NOS (1) • Dog Agitation (1) • Dog Acid-base disorder (1) • Dog Abnormal urine odour (1) • Dog Abnormal ultrasound finding (1) • Dog Abnormal radiograph finding (1) • Dog Abdominal pain (1) • Cat

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, ['Pit Bull', 'Crossbred Canine/dog'], Female, 2.67 year • Drug: MSK, Unknown • Reactions: Cough, Abnormal radiograph finding, Heart murmur, Eosinophilia, Lack of efficacy (endoparasite) - heartworm • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-013926
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Female
  • Age: 2.67 Year
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Cough Abnormal radiograph finding Heart murmur Eosinophilia Lack of efficacy (endoparasite) - heartworm
Outcomes: Ongoing

Dog, Shih Tzu, Female, 6 month, 3.175 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Soft stool, Not eating, Low amylase • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-012816
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 6.00 Month
  • Weight: 3.175 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Soft stool Not eating Low amylase
Outcomes: Ongoing

Dog, ['Retriever - Golden', 'Poodle (unspecified)'], Male, 3 year, 16.783 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Vomiting, Swelling around eye, Whining, Uncomfortable, Fever… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-012837
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 3.00 Year
  • Weight: 16.783 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Vomiting Swelling around eye Whining Uncomfortable Fever Injected sclera Pinnal erythema Hypersensitivity reaction
Outcomes: Ongoing

Dog, Chihuahua, Female, 8.25 year, 2.54 kilogram • Drug: MSK, Unassigned, Subcutaneous • Reactions: Muscle tremor, Opisthotonus, Rigidity of limbs, Star-gazing, Prolonged anaesthesia… • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2026-US-012640
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 8.25 Year
  • Weight: 2.540 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Unassigned
Reactions Reported:
Muscle tremor Opisthotonus Rigidity of limbs Star-gazing Prolonged anaesthesia Intentional misuse
Outcomes: Recovered/Normal

Dog, Dalmatian, Male, 10 year, 36.741 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Agitation, Drooling, Febrile, Panting, Anaphylaxis… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-012695
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 10.00 Year
  • Weight: 36.741 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Agitation Drooling Febrile Panting Anaphylaxis Unwell Decreased appetite Urinary incontinence Vomiting Diarrhea Leukocytosis NOS Neutrophilia Lymphocytosis Monocytosis Elevated globulins Elevated serum alkaline phosphatase Anaemia NOS Elevated alanine aminotransferase Elevated C-reactive protein Aggression Urolithiasis Autoimmune disorder NOS Thrombocytopenia
Outcomes: Ongoing

Cat, Persian, Female, 11 year, 3.36 kilogram • Drug: MSK, Subcutaneous • Reactions: Drooling • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2026-US-012003
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Female
  • Age: 11.00 Year
  • Weight: 3.360 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
Reactions Reported:
Drooling
Outcomes: Recovered/Normal

Dog, Terrier - Bull - Staffordshire, Male, 8 year, 30.617 kilogram • Drug: MSK, Injection, Parenteral, Dose: 1.50 mL per dose, Frequency: 1 per day • Reactions: Swollen limb, Injection site inflammation, Lack of efficacy • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2026-US-009390
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 8.00 Year
  • Weight: 30.617 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Parenteral
  • Form: Injection
  • Dose: 1.50 mL per dose
  • Frequency: 1 per day
Reactions Reported:
Swollen limb Injection site inflammation Lack of efficacy
Outcomes: Recovered/Normal

Dog, Retriever - Golden, Female, 6 year, 30.844 kilogram • Drug: MSK, Dose: 1.50 tablet per dose • Reactions: Localised pain NOS, Limb non-weight bearing, Swollen limb, Whining, Uncomfortable… • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2026-US-010643
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Female
  • Age: 6.00 Year
  • Weight: 30.844 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Dose: 1.50 tablet per dose
Reactions Reported:
Localised pain NOS Limb non-weight bearing Swollen limb Whining Uncomfortable Pain NOS Reluctant to move Inappropriate urination Abnormal urine odour Injection site bleeding Loss of appetite Injection site itching Injection site irritation Injection site self trauma Limping Injection site discharge NOS Skin irritation Reddening of the skin Alopecia local Injection site scratching Injection site swelling Injection site hair loss
Outcomes: Outcome Unknown

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

Store at room temperature.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.